BIOTRONIK is pleased to announce the release of the results of the BENEFIT-01 study published in Neuromodulation.1 The prospective, multi-center study was designed to investigate the influence of ...

Octapharma has released the results from its prospective, randomized, double-blind, parallel group, crossover, placebo-controlled phase 3 study comparing the effectiveness of PANZYGA® (immune globulin ...